Skip to search formSkip to main contentSkip to account menu

artemether 20 MG / lumefantrine 120 MG Oral Tablet

Known as: ARTEMETHER 20/LUMEFANTRINE 120MG TAB,24, ARTEMETHER 20MG/LUMEFANTRINE 120MG TAB,PKT,24, ARTEMETHER 20MG/LUMEFANTRINE 120MG TAB,PKT,24 [VA Product] 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (1)

Antimalarials
Oral Tabletartemetherartemether / lumefantrinelumefantrine

Narrower (1)

artemether 20 MG / lumefantrine 120 MG Oral Tablet [Coartem]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Assessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modelling
Artemether-lumefantrine (AL) is the most widely-recommended treatment for uncomplicated Plasmodium falciparum malaria worldwide… 
Review
2016
Review
2016
Erratum to: Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using…
After publication of the original article [1], it came to the authors’ attention that there is an error in the originally… 
Review
2014
Review
2014
A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission
While significant advances have been made in the prevention and treatment of malaria in recent years, these successes continue to… 
Review
2013
Review
2013
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
In vivo Therapeutic Efficacy Studies (TES) have been routinely conducted in the Greater Mekong Subregion (GMS) for decades… 
Review
2013
Review
2013
Access to artemisinin-based anti-malarial treatment and its related factors in rural Tanzania
BackgroundArtemisinin-based combination treatment (ACT) has been widely adopted as one of the main malaria control strategies… 
Review
2010
Review
2010
Improvements in access to malaria treatment in Tanzania following community, retail sector and health facility interventions -- a user perspective
BackgroundThe ACCESS programme aims at understanding and improving access to prompt and effective malaria treatment. Between 2004… 
Highly Cited
2010
Highly Cited
2010
Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective
BackgroundTo improve access to treatment in the private retail sector a new class of outlets known as accredited drug dispensing… 
2007
2007
In vitro interaction of dihydroartemisin and lumefantrine in clinical field isolates from Bangladesh
ZusammenfassungArtemether-Lumefantrin wurde im Jahr 2005 als offizielle Standardtherapie für die Behandlung der unkomplizierten… 
Highly Cited
2007
Highly Cited
2007
The role of pfmdr1 in Plasmodium falciparum tolerance to artemether‐lumefantrine in Africa
Objective  Artemether‐lumefantrine (AL), presently the most favoured combination therapy against uncomplicated Plasmodium… 
Highly Cited
2006
Highly Cited
2006
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria.
BACKGROUND Our study examined the relative contributions of host, pharmacokinetic, and parasitological factors in determining the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)